SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 18, 2026

RLAY

Relay Therapeutics, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed2mo ago
Insider cluster: 2 insiders, $1.3M total
Actionable Insight ▼ Bearish

The CEO+CFO simultaneous open-market sales without a 10b5-1 plan or disclosed catalyst is a cautionary signal for a high-valuation biotech. Monitor for upcoming pipeline data readouts or clinical trial updates that may have prompted insider selling. The 95% analyst bullish consensus creates downside risk if insiders are proven correct.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$20.74
T+0 close · Aug 18, 2026 · via day close
Latest settled
−4.92%
T+60 · $19.72
Vs SPY
−4.09%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 19 $20.74entry
  2. T+1 · 3mo ago −5.01%α −4.17% · $19.70
  3. T+5 · 3mo ago −6.17%α −5.78% · $19.46
  4. T+20 · 2mo ago −7.47%α −6.63% · $19.19
  5. T+60 · 5d ago −4.92%α −4.09% · $19.72
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Relay Therapeutics' CEO and CFO sold a combined $1.33M in open-market sales over a 4-day window, representing ~0.03% of the $4.5B market cap. While the dollar amount is trivial relative to company size, the cluster involves both the CEO and CFO selling simultaneously, which is notable for a biotech with a $4.5B market cap and 95% analyst bullishness. The sales are not part of a 10b5-1 plan pattern and occur without any disclosed negative catalyst, suggesting potential insider caution ahead of upcoming pipeline data or earnings.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
2

Key Facts

  • CEO Sanjiv Patel sold 48,199 shares for $979,886 on 2026-08-17
  • CFO Thomas Catinazzo sold 17,717 shares for $349,734 on 2026-08-14
  • Total insider sales of $1.33M represent ~0.03% of $4.5B market cap
  • Both sales are open-market (code S), not 10b5-1 plan or tax withholding
  • No recent positive catalyst or earnings release to explain selling
  • 95% of analysts rate the stock Buy/Strong Buy

Financial Impact

Insider sales of $1.33M, trivial relative to $4.5B market cap (0.03%)

insider ownershipmarket sentiment

Risk Factors

  • Insider sales may signal management's lack of confidence in near-term pipeline catalysts
  • High analyst bullishness (95% Buy/Strong Buy) creates asymmetric downside if sentiment shifts
  • No disclosed negative catalyst, selling could be diversification but timing is suspicious

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RLAY-1787121416661

Track record

21 reports on RLAY

Performance horizon

5 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +65.12% at T+60 after the May 19, 2026 report. 7 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G Neutral 4/10 Entry $17.68 Now $17.27 −2.29% settles Feb 12
  3. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  4. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $17.00 Now $17.27 +1.59% settles Feb 3
  5. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $17.44 Now $17.27 −0.97% settles Feb 1
  6. Oct 7, 20265w ago 144 Neutral 2/10 Entry $17.41 Now $17.27 −0.80% settles Jan 5
  7. Oct 6, 20265w ago 144 Neutral 3/10 Entry $17.95 Now $17.27 −3.79% settles Jan 4
  8. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $18.89 Now $17.27 −8.58% settles Dec 4
  9. Aug 28, 202611w ago Insider Cluster Bearish 6/10 Entry $18.77 Now $17.27 +7.99% settles Nov 23
  10. Aug 18, 202612w ago Insider Cluster Bearish 5/10 Viewing Entry $20.74 to $19.72 Now $17.27 +16.73% ▲ +4.92% +4.09% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Wed (9h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 19, 2026